Continuing education lectures on adult glioblastoma to be held at all U.S. healthcare centers

Download PDF Copy

Apr 30 2010

Adult glioblastoma continues to be a difficult disease to treat, so healthcare professionals must have the most up-to-date information regarding optimal methods for diagnostic imaging and treatment of these tumors. Awareness of novel agents in clinical trials is also critical to providing the best care.

To address the need for current education on adult glioblastoma diagnosis and treatment, Robert Michael Educational Institute LLC (RMEI) and Postgraduate Institute for Medicine (PIM) are jointly sponsoring a series of complimentary continuing education lectures at healthcare centers throughout the United States titled Current Perspectives in Adult Glioblastoma. This activity is supported by an educational grant from Merck.

Experts in neurology, neuro-oncology, and neurosurgery from leading medical institutions across the country will serve as faculty for this series, which is chaired by Marc C. Chamberlain, MD. Dr. Chamberlain is professor of neurology and neurological surgery and chief of the division of neuro-oncology at the University of Washington in Seattle.

Healthcare professionals can visit www.RMEI.com/GBlectures today to schedule a meeting at their institution.

Source:

Robert Michael Educational Institute LLC

Posted in: Medical Condition News | Healthcare News

Comments (0)

Download PDF Copy

Suggested Reading

Better education and income reduce anxiety about growing old

Experts call for coordinated global action to make the most of Alzheimer’s treatments

Healing with Artificial Intelligence highlights the future of patient care

Duke-NUS sharpens focus on population health and technology-enabled research

Aspartame triggers genetic changes tied to glioblastoma severity

AI transforms healthcare for faster, smarter care in emergency crises

Frontline clinicians report trauma patterns in Gaza exceeding previous warzones

AI rollout in NHS hospitals faces major challenges

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

(Logout)

Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.